scispace - formally typeset
Open AccessJournal ArticleDOI

Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline

Reads0
Chats0
TLDR
This systematic review aims to identify who is at high risk, how to prevent OHSS, and the treatment for existing OHSS.
About
This article is published in Fertility and Sterility.The article was published on 2016-12-01 and is currently open access. It has received 236 citations till now. The article focuses on the topics: Ovarian hyperstimulation syndrome & Guideline.

read more

Citations
More filters
Journal ArticleDOI

Forty years of IVF

Craig Niederberger, +71 more
TL;DR: This monograph, written by the pioneers of IVF and reproductive medicine, celebrates the history, achievements, and medical advancements made over the last 40 years in this rapidly growing field.
Journal ArticleDOI

Diagnosis and Management of Infertility: A Review.

TL;DR: The most common causes of infertility are ovulatory dysfunction, male factor infertility, and tubal disease as mentioned in this paper, and lifestyle and environmental factors such as smoking and obesity can adversely affect fertility.
Journal ArticleDOI

Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews

TL;DR: An overview of Cochrane systematic reviews on interventions for prevention or treatment of moderate, severe and overall OHSS in couples with subfertility who are undergoing ART cycles concludes that evidence is currently insufficient to support the widespread practice of embryo cryopreservation.
Reference EntryDOI

Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome

TL;DR: This review assesses the effect of "coasting" (withholding gonadotrophins) as a preventative strategy in the management of OHSS following superovulation in assisted reproduction treatment on the incidence of all clinical grades ofOHSS, in comparison with "early unilateral follicular aspiration (EUFA)" or other interventions.
References
More filters
Journal ArticleDOI

Gonadotrophin‐releasing hormone antagonists for assisted reproductive technology

TL;DR: Evaluating the effectiveness and safety of gonadotrophin-releasing hormone (GnRH) antagonists compared with the standard long protocol of GnRH agonists for controlled ovarian hyperstimulation in assisted conception cycles found no conclusive evidence of a difference in live birth rate and other adverse effects were secondary outcomes.
Journal ArticleDOI

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.

TL;DR: The use of a protocol consisting of GnRH agonist trigger after GnRH antagonist cotreatment combined with adequate luteal phase and early pregnancy E(2) and P supplementation reduces the risk of OHSS in high-risk patients undergoing IVF without affecting implantation rate.
Journal ArticleDOI

Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial

G Borm, +1 more
- 01 Jul 2000 - 
TL;DR: The results of this study support a safe, short and convenient treatment regimen of ganirelix, resulting in a good clinical outcome for patients undergoing ovarian stimulation for IVF or ICSI.
Journal ArticleDOI

Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology

TL;DR: To evaluate the effectiveness and safety of GnRH agonists in comparison with HCG for triggering final oocyte maturation in IVF and ICSI for women undergoing COH in a GnRH antagonist protocol, databases were searched and primary outcomes were live birth and rate of ovarian hyperstimulation syndrome (OHSS) per women randomised.
Related Papers (5)